360 related articles for article (PubMed ID: 26662314)
1. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
2. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
3. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.
Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J
Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity.
Mansoori Y; Tabei MB; Askari A; Izadi P; Daraei A; Bastami M; Naghizadeh MM; Nariman-Saleh-Fam Z; Mansoori B; Tavakkoly-Bazzaz J
Breast J; 2018 Nov; 24(6):876-882. PubMed ID: 29785740
[TBL] [Abstract][Full Text] [Related]
5. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
6. Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer.
Liang W; Lv T; Shi X; Liu H; Zhu Q; Zeng J; Yang W; Yin J; Song Y
Medicine (Baltimore); 2016 Sep; 95(37):e4608. PubMed ID: 27631209
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA GAS5 can predict metastasis and poor prognosis: a meta-analysis.
Song W; Wang K; Zhang RJ; Dai QX; Zou SB
Minerva Med; 2016 Feb; 107(1):70-6. PubMed ID: 26763654
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
Cao S; Liu W; Li F; Zhao W; Qin C
Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
[TBL] [Abstract][Full Text] [Related]
9. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer.
Özgür E; Ferhatoğlu F; Şen F; Saip P; Gezer U
Cancer Biomark; 2020; 27(1):11-17. PubMed ID: 31640083
[TBL] [Abstract][Full Text] [Related]
10. Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer.
Guo LJ; Zhang S; Gao B; Jiang Y; Zhang XH; Tian WG; Hao S; Zhao JJ; Zhang G; Hu CY; Yan J; Luo DL
Exp Mol Pathol; 2017 Jun; 102(3):500-504. PubMed ID: 28506768
[TBL] [Abstract][Full Text] [Related]
11. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
[TBL] [Abstract][Full Text] [Related]
12. Circulating long noncoding RNAs H19 and GAS5 are associated with type 2 diabetes but not with diabetic retinopathy: A preliminary study.
Fawzy MS; Abdelghany AA; Toraih EA; Mohamed AM
Bosn J Basic Med Sci; 2020 Aug; 20(3):365-371. PubMed ID: 31999937
[TBL] [Abstract][Full Text] [Related]
13. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
[TBL] [Abstract][Full Text] [Related]
14. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
Tang Y; Wang Y; Wang X; Liu Y; Zheng K
Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
[TBL] [Abstract][Full Text] [Related]
15. The use of Human Inflammatory Response and Autoimmunity RT2 lncRNA PCR Array for plasma examination in breast cancer patients prior to therapy.
Sterbova M; Pazourkova E; Santorova-Pospisilova S; Zednikova I; Tesarova P; Korabecna M
Neoplasma; 2019 Jul; 66(4):641-646. PubMed ID: 30943749
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
17. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?
Fayda M; Isin M; Tambas M; Guveli M; Meral R; Altun M; Sahin D; Ozkan G; Sanli Y; Isin H; Ozgur E; Gezer U
Tumour Biol; 2016 Mar; 37(3):3969-78. PubMed ID: 26482616
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
[TBL] [Abstract][Full Text] [Related]
19. Detection and analysis of circulating large intergenic non-coding RNA regulator of reprogramming in plasma for breast cancer.
Zhang K; Luo Z; Zhang Y; Wang Y; Cui M; Liu L; Zhang L; Liu J
Thorac Cancer; 2018 Jan; 9(1):66-74. PubMed ID: 29090518
[TBL] [Abstract][Full Text] [Related]
20. Unleash multifunctional role of long noncoding RNAs biomarker panel in breast cancer: a predictor classification model.
Toraih EA; El-Wazir A; Ageeli EA; Hussein MH; Eltoukhy MM; Killackey MT; Kandil E; Fawzy MS
Epigenomics; 2020 Jul; 12(14):1215-1237. PubMed ID: 32812439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
